OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Organizing folders is not my forte. I didn't even give it a second thought after I set up my computer once. My Windows PC has virtual machine and game folders on one of them, and media files, family ...

Computational Modeling of Failure at the Fabric Weave Level in Reentry Parachute Energy ModulatorsEnergy modulators (EM) are textile ...

Atek Midas, a Turkish company, has launched DSG-22.6 GHz, a high-performance, open-source RF signal generator designed to provide professional-grade ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

This course was written back in the good old days when Gitpod offered users 50 hours of free work per month. But that was a long time ago, and now this service has become paid. Fortunately, you can ...